Demand for testing unregulated peptides is rising in New Zealand, and a local singer is pushing for the same drug checking services that exist for party drugs.
Recap by typeshit. Post by @thepostnz on Instagram.
Reuters reports the trend among GLP-1 users is prompting calls for tighter rules on supplements sold alongside the drugs.
A pharmacist account flags two separate Class II recalls involving compounded tirzepatide. Tap through for which products are affected and why.
Health authorities in New South Wales issued a warning after a jump in hospitalisations linked to unapproved peptides sold as wellness products.
A University of Iowa chemist found no peptide in a Brooklyn corner-store vial, and another expert flagged at least 13 bacterial colonies that could cause infection.
A group of MPs is pressing for faster access to Mounjaro through the NHS, Sky News reports.
AG Information Network of the West looks at GLP-1 users' effect on protein demand, alongside news on a US trade deal with Mexico.
Loading…